Literature DB >> 8572872

The nigrostriatal dopamine system and the development of hypertension in the spontaneously hypertensive rat.

W de Jong1, A C Linthorst, H G Versteeg.   

Abstract

Several observations reported in the literature reveal a role of brain catecholaminergic systems in the development of hypertension in spontaneously hypertensive rats (SHR). As reviewed here, our results obtained with intracerebroventricular injections of 6-hydroxydopamine in your SHR point in particular to the involvement of the nigrostriatal dopamine system. The electrically stimulated release of radiolabeled dopamine in vitro from caudate nucleus slices of SHR was lower than that in slices of normotensive Wistar-Kyoto rats (WKY). Using an in vivo microdialysis method, we found that the extracellular concentration of dopamine and the metabolite DOPAC was lower in the caudate nucleus of conscious SHR than in that of WKY. We also studied the effects of lesions of the pars compacta of the substantia nigra of 4 week-old SHR and WKY, 1) on blood pressure and heart rate, 2) on the concentrations of dopamine and metabolites in the caudate nucleus and 3) on the release of radiolabeled dopamine from caudate nucleus slices using an in vitro superfusion method, 6 weeks following lesioning. Substantia nigra lesions caused a profound attenuation of the development of hypertension in SHR, with no effect on heart rate. The ratios DOPAC/dopamine and HVA/dopamine were lower in sham-treated SHR than in sham-treated WKY pointing to a lower turnover of dopamine in SHR. Six weeks after lesioning, the concentrations of dopamine were decreased in the caudate nucleus of both strains. At this time, the stimulus-evoked release of dopamine from the remaining terminals was significantly increased in caudate nucleus slices of SHR but not in slices of WKY. Thus, whereas the release of dopamine from caudata nucleus slices is lower in sham-treated SHR than in sham-treated WKY, lesioning of the substantia nigra results in a similar release of dopamine from caudate nucleus slices of lesioned SHR and sham-treated WKY. This normalization of dopaminergic activity may be the causal factor underlying the attenuation of the development of hypertension in SHR after bilateral lesioning of the pars compacta, of the substantia nigra.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8572872

Source DB:  PubMed          Journal:  Arch Mal Coeur Vaiss        ISSN: 0003-9683


  13 in total

1.  Presynaptic modulation of K+-evoked [3H]dopamine release in striatal and frontal cortical synaptosomes of normotensive and spontaneous-hypertensive rats.

Authors:  M A Yousfi-Alaoui; S Hospital; A Garcia-Sanz; A Badia; M V Clos
Journal:  Neurochem Res       Date:  2001-12       Impact factor: 3.996

2.  Set shifting in a rodent model of attention-deficit/hyperactivity disorder.

Authors:  Amy C Chess; Brittany E Raymond; Ira G Gardner-Morse; Mark R Stefani; John T Green
Journal:  Behav Neurosci       Date:  2011-06       Impact factor: 1.912

Review 3.  Review of rodent models of attention deficit hyperactivity disorder.

Authors:  Samantha L Regan; Michael T Williams; Charles V Vorhees
Journal:  Neurosci Biobehav Rev       Date:  2021-11-27       Impact factor: 8.989

4.  In vitro glutamate-stimulated release of dopamine from nucleus accumbens core and shell of spontaneously hypertensive rats.

Authors:  Vivienne Ann Russell
Journal:  Metab Brain Dis       Date:  2003-06       Impact factor: 3.584

5.  Adult zebrafish in CNS disease modeling: a tank that's half-full, not half-empty, and still filling.

Authors:  Darya A Meshalkina; Elana V Kysil; Jason E Warnick; Konstantin A Demin; Allan V Kalueff
Journal:  Lab Anim (NY)       Date:  2017-10-06       Impact factor: 12.625

6.  NMDA receptor function in the prefrontal cortex of a rat model for attention-deficit hyperactivity disorder.

Authors:  Molupe Lehohla; Lauriston Kellaway; Vivienne Ann Russell
Journal:  Metab Brain Dis       Date:  2004-06       Impact factor: 3.584

7.  Meditation-based training: a possible intervention for attention deficit hyperactivity disorder.

Authors:  Shruti Baijal; Rashmi Gupta
Journal:  Psychiatry (Edgmont)       Date:  2008-04

8.  Animal models of attention-deficit hyperactivity disorder.

Authors:  Vivienne A Russell; Terje Sagvolden; Espen Borgå Johansen
Journal:  Behav Brain Funct       Date:  2005-07-15       Impact factor: 3.759

9.  Calcyon mRNA expression in the frontal-striatal circuitry and its relationship to vesicular processes and ADHD.

Authors:  Rochellys Diaz Heijtz; Andrey Alexeyenko; F Xavier Castellanos
Journal:  Behav Brain Funct       Date:  2007-07-10       Impact factor: 3.759

10.  Cross-fostering does not alter the neurochemistry or behavior of spontaneously hypertensive rats.

Authors:  Fleur M Howells; Leander Bindewald; Vivienne A Russell
Journal:  Behav Brain Funct       Date:  2009-06-23       Impact factor: 3.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.